glucokinase activators (Bristol-Myers Squibb)

N/A

Report date: 2025/01/26 18:10:38
NME

Base Information

Drug Nameglucokinase activators (Bristol-Myers Squibb)
Drug Alias NameBMS-212
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucokinase activators
TargetsGlucokinase
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A